Coherus Oncology, Inc. Common Stock
CHRS
CHRS
156 hedge funds and large institutions have $278M invested in Coherus Oncology, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 49 increasing their positions, 53 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
156
Holders Change
-13
Holders Change %
-7.69%
% of All Funds
2.29%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
32
Increased
49
Reduced
53
Closed
42
Calls
$3.15M
Puts
$1.19M
Net Calls
+$1.96M
Net Calls Change
+$1.35M
Top Buyers
| 1 |
Millennium Management
New York
|
$9.46M |
| 2 |
Two Sigma Investments
New York
|
$4.83M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$5.38M |
| 4 |
Barclays
London,
United Kingdom
|
$11.6M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$3.77M |
